Ignite Creation Date:
2024-05-06 @ 12:32 PM
Last Modification Date:
2024-10-26 @ 1:00 PM
Study NCT ID:
NCT03780608
Status:
UNKNOWN
Last Update Posted:
2022-06-15
First Post:
2018-12-18
Brief Title:
This Study is a Phase II Study of AZD6738 in Combination With Durvalumab in Patients With Solid Tumor Cohort A N30 GC Who Have Failed Secondary Chemotherapy Treatments Regimen Cohort B B30 Melanoma Patients Who Have Failed to IO
Sponsor:
Organization:
Samsung Medical Center